Text size :

Research: Gilead awards 62 projects with over 1.2 million euros (2)

ADNKRONOS

November 4, 2026

(Adnkronos Health) – The Gilead Calls – the note details – have established themselves over these fifteen years “as a virtuous example of public-private collaboration capable of generating value and innovation at scientific, organizational, and assistance levels.” The milestone of the 15th edition represented an opportunity, based on the experience of the Calls, “to promote a broader reflection on innovation in healthcare and the necessary conditions to transform it into concrete, widespread, and sustainable benefits for the country.” The topic was at the center of a round table that compared different perspectives: infectious disease specialist Massimo Andreoni, Davide Petruzzelli, president of La Lampada di Aladino Ets and vice-president of Favo; Massimo Farinella, head of the Anlaids Health Area; Senator Guido Quintino Liris (V Permanent Budget Committee); deputies Gian Antonio Girelli (XII Social Affairs Committee of the Chamber), Simona Loizzo (XII Social Affairs Committee of the Chamber) and Frederico da Silva, Vice President & General Manager of Gilead Sciences Italy.

“In a complex macroeconomic context like the current one, investing in innovation means investing in the country’s ability to grow and remain competitive. A vision and planning capable of viewing innovation as an investment for the future are needed. The challenge is to create the conditions for resources allocated to innovation to generate value over time, through effective collaboration between institutions and all stakeholders in the health system,” states Antonio Girelli. “Today, innovation in healthcare is also measured by the ability to anticipate people’s needs, ensure equitable access to care, and leverage the opportunities offered by prevention, screenings, and digital technology. It is necessary to continue investing in these tools and translate them into concrete care pathways, overcoming territorial inequalities and ensuring all citizens the same health rights,” emphasizes Simona Loizzo.

“For fifteen years, the Gilead Calls have represented a concrete example of how our commitment goes beyond the development of innovative therapies and contributes to supporting independent research and assistance activities promoted by the Third Sector,” concludes Frederico da Silva. “The partnership between public and private sectors is one of the levers we have available to continue generating innovation capable of translating into value for people and for the health system. At the same time, in an increasingly challenging international scenario, it is important to be able to count on an ecosystem capable of recognizing and valuing the contribution of companies that choose to invest in research and innovation in our country, creating the conditions for Italy to continue attracting investments and skills.”

Jiji Press

Related

Page TOP